15
Cirrhosis Ziyi Fan

Cirrhosis - University of Virginia School of Medicine

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Cirrhosis - University of Virginia School of Medicine

Cirrhosis

Ziyi Fan

Page 2: Cirrhosis - University of Virginia School of Medicine

Case• CW is a 54 yo woman with history of

EtOH/HCV cirrhosis presenting with abdominal distension and pain

Page 3: Cirrhosis - University of Virginia School of Medicine
Page 4: Cirrhosis - University of Virginia School of Medicine
Page 5: Cirrhosis - University of Virginia School of Medicine
Page 6: Cirrhosis - University of Virginia School of Medicine

US LiverLiver:

Size: ShrunkenEchogenicity: Coarse and heterogeneous echotextureSurface Contour: Nodular surface contourObservation: Large recanalized paraumbilical vein

Fluid: Large volume ascites.

Page 7: Cirrhosis - University of Virginia School of Medicine

Liver biopsy• Indications Diagnosis

• Unknown etiology• Coexisting disorders• Focal/diffuse

abnormalities on imaging

• FUO

Prognosis• Disease severity, esp

degree of fibrosis Management

• Disease specific treatments

• Initiation of treatment• Monitoring

progression, response

Page 8: Cirrhosis - University of Virginia School of Medicine
Page 9: Cirrhosis - University of Virginia School of Medicine

Nonfocal liver biopsy• Percutaneous• US guided

– Real-time visualization– No ionizing radiation– Quick, less expensive– Reduced pain

• Core– Irregular distribution– Long and wide, ideally

3 cm, 16 gauge needle

• Main complication: Bleeding

Page 10: Cirrhosis - University of Virginia School of Medicine

Pathology• Formalin fixation• Histochemical

– H & E– Masson trichrome

• Immunohistochemical• Regenerative nodules surrounded by fibrous

connective tissue

Page 11: Cirrhosis - University of Virginia School of Medicine

HCV cirrhosis• Periportal fibrosis,

septal fibrosis• Sinusoidal

lymphocytic infiltrate

Page 12: Cirrhosis - University of Virginia School of Medicine

Alcoholic cirrhosis• Mallory bodies• Centrilobular

perivenularfibrosis

Page 13: Cirrhosis - University of Virginia School of Medicine

Treatment• Slow/reverse progression of liver disease

– Abstinence from EtOH– Anti-virals for HCV

• Prevent superimposed insults– Vaccinations– Avoid hepatotoxins

• Prevent/manage complications

Page 14: Cirrhosis - University of Virginia School of Medicine

Prognosis• Compensated: median survival > 12 yrs• Decompensated: median survival ≤ 6 mos if

Child-Pugh ≥ 12 or MELD ≥ 21– If hx of hospitalization for acute liver-related

illness, ≤ 6 mos if Child-Pugh ≥ 12 or MELD ≥ 18

Page 15: Cirrhosis - University of Virginia School of Medicine

Sources• Clin Mol Hepatol. 2017 Dec; 23(4): 302–307. • Hepatology. 2009 Mar;49(3):1017-44.• https://webpath.med.utah.edu/LIVEHTML/LIVERIDX.html#

2• http://www.pathologyoutlines.com/topic/livercirrhosisalco

holic.html• https://www.pathologyoutlines.com/topic/liverhepC.html• Uptodate article on cirrhosis